SCHEMBL10746138

SCHEMBL10746138

CC(C)(C)c1nnc(-n2[se]c3ccccc3c2=S)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ PKM P14618 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ METAP2 P50579 7/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ QSOX1 O00391 1/20 0.33
▸ RGS12 O14924 1/20 0.33
▸ PMM2 O15305 1/20 0.33
▸ PLIN1 O60240 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ BBOX1 O75936 1/20 0.33
▸ TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10747704 0.86 HTT (0.41) ALDH1A1LMNAPKMNPC1RAB9A
SCHEMBL10748416 0.85 METAP2 (0.48) ALDH1A1LMNAPKMKDM4EMAPT
SCHEMBL10746643 0.81 METAP2 (0.38) ALDH1A1LMNAPKMNPC1RAB9A
SCHEMBL10745614 0.78 METAP2 (0.35) ALDH1A1LMNAPKMKDM4EMAPT
SCHEMBL10502231 0.74 METAP2 (0.37) ALDH1A1LMNAPKMKDM4EMAPT
SCHEMBL10749736 0.72 KDM4E (0.35) ALDH1A1LMNAPKMKDM4EMAPT
SCHEMBL10501392 0.71 METAP2 (0.34) ALDH1A1LMNAPKMKDM4EMAPT
SCHEMBL10501619 0.71 EP300 (0.45) ALDH1A1LMNAPKMRAB9ASMN1; SMN2
SCHEMBL10744989 0.71 KAT2A (0.47) ALDH1A1LMNANPC1RAB9ASMN1; SMN2
SCHEMBL10764046 0.71 METAP2 (0.48) ALDH1A1LMNAPKMKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
Send feedback